oseltamivir has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulkhalek, S; Alghamdi, F; Arvizu, LA; Cheng, TS; Geen, O; Gilmour, AM; Jayanth, P; O'Shea, LK; Szewczuk, MR | 1 |
| Abdulkhalek, S; Allison, S; Ellis, JP; Haxho, F; Hrynyk, M; Neufeld, RJ; Steele, JA; Szewczuk, MR | 1 |
2 other study(ies) available for oseltamivir and Cancer of Pancreas
| Article | Year |
|---|---|
A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Neuraminidase; NIH 3T3 Cells; Oseltamivir; Pancreas; Pancreatic Neoplasms; Signal Transduction | 2013 |
Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma.
Topics: Absorbable Implants; Angiogenesis Inhibitors; Animals; Antigens, CD; Cadherins; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Implants; Interleukin Receptor Common gamma Subunit; Liver Neoplasms; Lung Neoplasms; Mice, Inbred NOD; Mice, Knockout; Neovascularization, Pathologic; Oseltamivir; Pancreatic Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; Solubility; Time Factors; Xenograft Model Antitumor Assays | 2015 |